Recainam

DB20085ExperimentalSmall molecule

Recainam is a small molecule drug. The usage of the INN stem '-cain-' in the name indicates that Recainam is a class I antiarrhythmic, procainamide and lidocaine derivative. Recainam has... Recainam has a monoisotopic molecular weight of 263.2 Da.

Mechanism: Pharmacologically active on Sodium channel protein and Voltage-gated sodium channel alpha subunit
Curator reviewed
Formula / weight: C₁₅H₂₅N₃O · 263.385 g/mol (avg)
Code names: WY-42,362

Resolves to

Compound

UNII646KRE84ZGCAS74738-24-2ChEMBLCHEMBL551786ChEBI749069PubChem53084

Structure

InChIKeyWHJSFPCTWYLZRC-UHFFFAOYSA-NSMILESCC(C)NCCCNC(=O)NC1=C(C)C=CC=C1C

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of Recainam, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account